Evidence map›Paper›PMID 31060051›Full record

ArticleInvestigative ophthalmology & visual science2019

Increased ER Stress After Experimental Ischemic Optic Neuropathy and Improved RGC and Oligodendrocyte Survival After Treatment With Chemical Chaperon.

Varun Kumar, Louise Alessandra Mesentier-Louro, Angela Jinsook Oh, Kathleen Heng, Mohammad Ali Shariati, Haoliang Huang, Yang Hu, Yaping Joyce Liao

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 19 citations in OpenAlex.

  1. Targeting prostaglandin catabolism via topical nanotherapy rescues vision in ischemic optic neuropathy.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Effects of MgSOInternational journal of molecular sciences · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Varun KumarDepartment of Ophthalmology, Stanford University, School of Medicine, Stanford, California, United States.
Louise Alessandra Mesentier-LouroDepartment of Ophthalmology, Stanford University, School of Medicine, Stanford, California, United States.
Angela Jinsook OhDepartment of Ophthalmology, Stanford University, School of Medicine, Stanford, California, United States.
Kathleen HengDepartment of Ophthalmology, Stanford University, School of Medicine, Stanford, California, United States.
Mohammad Ali ShariatiDepartment of Ophthalmology, Stanford University, School of Medicine, Stanford, California, United States.
Haoliang HuangDepartment of Ophthalmology, Stanford University, School of Medicine, Stanford, California, United States.
Yang HuDepartment of Ophthalmology, Stanford University, School of Medicine, Stanford, California, United States.
Yaping Joyce LiaoDepartment of Ophthalmology, Stanford University, School of Medicine, Stanford, California, United States.
Stanford University · US

Funding

Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2017 to 2026
$8.0M
Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve RegenerationR01EY024932 · NEI · TEMPLE UNIV OF THE COMMONWEALTH · PI Yang Hu · 2015 to 2026
$4.8M
Neuroprotection by Modulating ER Stress in GlaucomaR01EY023295 · NEI · TEMPLE UNIV OF THE COMMONWEALTH · PI HU, YANG · 2013 to 2022
$3.8M
Developing Novel Neuroprotective Strategies for EAE/Optic NeuritisR01EY028106 · NEI · STANFORD UNIVERSITY · PI HU, YANG · 2018 to 2021
$1.9M
NEI NIH HHS P30 EY026877NEI NIH HHS R01 EY023295NEI NIH HHS R01 EY024932NEI NIH HHS R01 EY028106
6 · The paper itself

Abstract

Purpose: Increased endoplasmic reticulum (ER) stress is one of the earliest subcellular changes in neuro-ophthalmic diseases. In this study, we investigated the expression of key molecules in the ER stress pathways following nonarteritic anterior ischemic optic neuropathy (AION), the most common acute optic neuropathy in adults over 50, and assessed the impact of chemical chaperon 4-phenylbutyric acid (4-PBA) in vivo. Methods: We induced AION using photochemical thrombosis in adult mice and performed histologic analyses of key molecules in the ER stress pathway in the retina and optic nerve. We also assessed the effects of daily intraperitoneal injections of 4-PBA after AION. Results: In the retina at baseline, there was low proapoptotic transcriptional regulator C/EBP homologous protein (CHOP) and high prosurvival chaperon glucose-regulated protein 78 (GRP78) expression in retinal ganglion cells (RGCs). One day after AION, there was significantly increased CHOP and reduced GRP78 expressions in the ganglion cell layer. In the optic nerve at baseline, there was little CHOP and high GRP78 expression. One day after AION, there was significantly increased CHOP and no change in GRP78 expression. Treatment immediately after AION using daily intraperitoneal injection of chemical chaperone 4-PBA for 19 days significantly rescued Brn3A+ RGCs and Olig2+ optic nerve oligodendrocytes. Conclusions: We showed for the first time that acute AION resulted in increased ER stress and differential expression of ER stress markers CHOP and GRP78 in the retina and optic nerve. Rescue of RGCs and oligodendrocytes with 4-PBA provides support for ER stress reduction as possible treatment for AION.

Indexed as

Endoplasmic Reticulum StressAnimalsDisease Models, AnimalEndoplasmic Reticulum Chaperone BiPFemaleGene Expression RegulationHeat-Shock ProteinsMaleMiceMice, Inbred C57BLMolecular ChaperonesOligodendrogliaOptic DiskOptic Neuropathy, IschemicPhenylbutyratesRetinal Ganglion Cells4-phenylbutyric acidDdit3 protein, mouseEndoplasmic Reticulum Chaperone BiPHeat-Shock ProteinsHspa5 protein, mouseMolecular ChaperonesPhenylbutyratesTranscription Factor CHOP

Identifiers

PMID31060051
PMCPMC6735778
OpenAlexW2943688794

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.